Clinical Trial Update: Topiramate and Severe Obesity [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating topiramate for obesity in children and adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Obese Children and Adolescents | Phase 3 | Status: COMPLETED